KRAS c.204G>C ;(p.R68S)

Variant ID: 12-25380254-C-G

NM_004985.3(KRAS):c.204G>C;(p.R68S)

This variant was identified in 57 publications

View GRCh38 version.




Publications:


Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS.

Signal Transduction And Targeted Therapy
Yin, Guowei G; Huang, Jing J; Petela, Johnny J; Jiang, Hongmei H; Zhang, Yuetong Y; Gong, Siqi S; Wu, Jiaxin J; Liu, Bei B; Shi, Jianyou J; Gao, Yijun Y
Publication Date: 2023-05-23

Variant appearance in text: KRAS: R68S
PubMed Link: 37221195
Variant Present in the following documents:
  • Main text
  • 41392_2023_Article_1441.pdf
View BVdb publication page



The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers.

Cancers
Tria, Simon Manuel SM; Burge, Matthew E ME; Whitehall, Vicki L J VLJ
Publication Date: 2023-04-19

Variant appearance in text: KRAS: R68S
PubMed Link: 37190303
Variant Present in the following documents:
  • Main text
  • cancers-15-02375.pdf
View BVdb publication page



The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation.

Therapeutic Advances In Gastroenterology
Jeong, Sun Young SY; Hong, Jung Yong JY; Park, Joon Oh JO; Park, Young Suk YS; Lim, Ho Yeong HY; Jang, Jae Yeon JY; Jeon, Youngkyung Y; Kim, Seung Tae ST
Publication Date: 2023

Variant appearance in text: KRAS: R68S
PubMed Link: 37163165
Variant Present in the following documents:
  • Main text
  • 10.1177_17562848231170484.pdf
View BVdb publication page



Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA.

Nature
Abbosh, Christopher C; Frankell, Alexander M AM; Harrison, Thomas T; Kisistok, Judit J; Garnett, Aaron A; Johnson, Laura L; Veeriah, Selvaraju S; Moreau, Mike M; Chesh, Adrian A; Chaunzwa, Tafadzwa L TL; Weiss, Jakob J; Schroeder, Morgan R MR; Ward, Sophia S; Grigoriadis, Kristiana K; Shahpurwalla, Aamir A; Litchfield, Kevin K; Puttick, Clare C; Biswas, Dhruva D; Karasaki, Takahiro T; Black, James R M JRM; Martínez-Ruiz, Carlos C; Bakir, Maise Al MA; Pich, Oriol O; Watkins, Thomas B K TBK; Lim, Emilia L EL; Huebner, Ariana A; Moore, David A DA; Godin-Heymann, Nadia N; L'Hernault, Anne A; Bye, Hannah H; Odell, Aaron A; Roberts, Paula P; Gomes, Fabio F; Patel, Akshay J AJ; Manzano, Elizabeth E; Hiley, Crispin T CT; Carey, Nicolas N; Riley, Joan J; Cook, Daniel E DE; Hodgson, Darren D; Stetson, Daniel D; Barrett, J Carl JC; Kortlever, Roderik M RM; Evan, Gerard I GI; Hackshaw, Allan A; Daber, Robert D RD; Shaw, Jacqui A JA; Aerts, Hugo J W L HJWL; Licon, Abel A; Stahl, Josh J; Jamal-Hanjani, Mariam M; , ; Birkbak, Nicolai J NJ; McGranahan, Nicholas N; Swanton, Charles C
Publication Date: 2023-04-13

Variant appearance in text: KRAS: R68S
PubMed Link: 37055640
Variant Present in the following documents:
  • EMS176197-supplement-Supplementary_Table_1.xlsx, sheet 18
View BVdb publication page



Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors.

Elife
Goebel, Lisa L; Kirschner, Tonia T; Koska, Sandra S; Rai, Amrita A; Janning, Petra P; Maffini, Stefano S; Vatheuer, Helge H; Czodrowski, Paul P; Goody, Roger S RS; Müller, Matthias P MP; Rauh, Daniel D
Publication Date: 2023-03-27

Variant appearance in text: KRAS: R68S
PubMed Link: 36972177
Variant Present in the following documents:
  • Main text
View BVdb publication page



Direct GDP-KRASG12C inhibitors and mechanisms of resistance: the tip of the iceberg.

Therapeutic Advances In Medical Oncology
Rosen, Joshua C JC; Sacher, Adrian A; Tsao, Ming-Sound MS
Publication Date: 2023

Variant appearance in text: KRAS: R68S
PubMed Link: 36950276
Variant Present in the following documents:
  • Main text
  • 10.1177_17588359231160141.pdf
View BVdb publication page



Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review.

Translational Lung Cancer Research
Santarpia, Mariacarmela M; Ciappina, Giuliana G; Spagnolo, Calogera Claudia CC; Squeri, Andrea A; Passalacqua, Maria Ilenia MI; Aguilar, Andrés A; Gonzalez-Cao, Maria M; Giovannetti, Elisa E; Silvestris, Nicola N; Rosell, Rafael R
Publication Date: 2023-02-28

Variant appearance in text: KRAS: R68S
PubMed Link: 36895930
Variant Present in the following documents:
  • Main text
  • tlcr-12-02-346.pdf
View BVdb publication page



Combined KRAS G12C and SOS1 inhibition enhances and extends the anti-tumor response in KRAS G12C -driven cancers by addressing intrinsic and acquired resistance.

Biorxiv : The Preprint Server For Biology
Thatikonda, Venu V; Lu, Hengyu H; Jurado, Sabine S; Kostyrko, Kaja K; Bristow, Christopher A CA; Bosch, Karin K; Feng, Ningping N; Gao, Sisi S; Gerlach, Daniel D; Gmachl, Michael M; Lieb, Simone S; Jeschko, Astrid A; Machado, Annette A AA; Marszalek, Ethan D ED; Mahendra, Mikhila M; Jaeger, Philipp A PA; Sorokin, Alexey A; Strauss, Sandra S; Trapani, Francesca F; Kopetz, Scott S; Vellano, Christopher P CP; Petronczki, Mark M; Kraut, Norbert N; Heffernan, Timothy P TP; Marszalek, Joseph R JR; Pearson, Mark M; Waizenegger, Irene I; Hofmann, Marco H MH
Publication Date: 2023-01-23

Variant appearance in text: KRAS: R68S
PubMed Link: 36747713
Variant Present in the following documents:
  • Main text
  • media-1.xlsx, sheet 4
  • nihpp-2023.01.23.525210v1.pdf
View BVdb publication page



Targeting KRASG12C in colorectal cancer: the beginning of a new era.

Esmo Open
Ciardiello, D D; Maiorano, B A BA; Martinelli, E E
Publication Date: 2022-12-20

Variant appearance in text: KRAS: R68S
PubMed Link: 36549128
Variant Present in the following documents:
  • Main text
View BVdb publication page



How to manage KRAS G12C-mutated advanced non-small-cell lung cancer.

Drugs In Context
Ricciuti, Biagio B; Mira, Alessia A; Andrini, Elisa E; Scaparone, Pietro P; Michelina, Sandra Vietti SV; Pecci, Federica F; Cantini, Luca L; De Giglio, Andrea A; Lamberti, Giuseppe G; Ambrogio, Chiara C; Metro, Giulio G
Publication Date: 2022

Variant appearance in text: KRAS: R68S
PubMed Link: 36452878
Variant Present in the following documents:
  • Main text
  • dic-2022-7-4.pdf
View BVdb publication page



In Silico Study of the Acquired Resistance Caused by the Secondary Mutations of KRAS G12C Protein Using Long Time Molecular Dynamics Simulation and Markov State Model Analysis.

International Journal Of Molecular Sciences
Tu, Gao G; Liu, Qing Q; Qiu, Yue Y; Leung, Elaine Lai-Han EL; Yao, Xiaojun X
Publication Date: 2022-11-10

Variant appearance in text: KRAS: R68S
PubMed Link: 36430323
Variant Present in the following documents:
  • Main text
  • ijms-23-13845.pdf
View BVdb publication page



Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications
Boström, Martin M; Larsson, Erik E
Publication Date: 2022-11-17

Variant appearance in text: KRAS: R68S
PubMed Link: 36396655
Variant Present in the following documents:
  • 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



Enhancing an Oxidative "Trojan Horse" Action of Vitamin C with Arsenic Trioxide for Effective Suppression of KRAS-Mutant Cancers: A Promising Path at the Bedside.

Cells
Burska, Agata N AN; Ilyassova, Bayansulu B; Dildabek, Aruzhan A; Khamijan, Medina M; Begimbetova, Dinara D; Molnár, Ferdinand F; Sarbassov, Dos D DD
Publication Date: 2022-11-01

Variant appearance in text: KRAS: R68S
PubMed Link: 36359850
Variant Present in the following documents:
  • Main text
  • cells-11-03454.pdf
View BVdb publication page



KRAS in NSCLC: State of the Art and Future Perspectives.

Cancers
Cascetta, Priscilla P; Marinello, Arianna A; Lazzari, Chiara C; Gregorc, Vanesa V; Planchard, David D; Bianco, Roberto R; Normanno, Nicola N; Morabito, Alessandro A
Publication Date: 2022-11-04

Variant appearance in text: KRAS: R68S
PubMed Link: 36358848
Variant Present in the following documents:
  • Main text
  • cancers-14-05430.pdf
View BVdb publication page



Molecular characterization of acquired resistance to KRAS G12C-EGFR inhibition in colorectal cancer.

Cancer Discovery
Yaeger, Rona R; Mezzadra, Riccardo R; Sinopoli, Jenna J; Bian, Yu Y; Marasco, Michelangelo M; Kaplun, Esther E; Gao, Yijun Y; Zhao, HuiYong H; Da Cruz Paula, Arnaud A; Zhu, Yingjie Y; Chaves Perez, Almudena A; Chadalavada, Kalyani K; Tse, Edison E; Chowdhry, Sudhir S; Bowker, Sydney S; Chang, Qing Q; Qeriqi, Besnik B; Weigelt, Britta B; Nanjangud, Gouri J GJ; Berger, Michael F MF; Der-Torossian, Hirak H; Anderes, Kenna K; Socci, Nicholas D ND; Shia, Jinru J; Riely, Gregory J GJ; Murciano-Goroff, Yonina R YR; Li, Bob T BT; Christensen, James G JG; Reis-Filho, Jorge S JS; Solit, David B DB; de Stanchina, Elisa E; Lowe, Scott W SW; Rosen, Neal N; Misale, Sandra S
Publication Date: 2022-11-10

Variant appearance in text: KRAS: R68S
PubMed Link: 36355783
Variant Present in the following documents:
  • 41.pdf
  • cd-22-0405_supplementary_table_3_suppst3.xlsx, sheet 1
View BVdb publication page



Targeting RAS mutants in malignancies: successes, failures, and reasons for hope.

Cancer Communications (London, England)
Yang, Hang H; Zhou, Xinyi X; Fu, Dongliang D; Le, Chenqin C; Wang, Jiafeng J; Zhou, Quan Q; Liu, Xiangrui X; Yuan, Ying Y; Ding, Kefeng K; Xiao, Qian Q
Publication Date: 2022-10-31

Variant appearance in text: KRAS: R68S
PubMed Link: 36316602
Variant Present in the following documents:
  • Main text
  • CAC2-43-42.pdf
View BVdb publication page



Drugging KRAS: current perspectives and state-of-art review.

Journal Of Hematology & Oncology
Parikh, Kaushal K; Banna, Giuseppe G; Liu, Stephen V SV; Friedlaender, Alex A; Desai, Aakash A; Subbiah, Vivek V; Addeo, Alfredo A
Publication Date: 2022-10-25

Variant appearance in text: KRAS: R68S
PubMed Link: 36284306
Variant Present in the following documents:
  • Main text
  • 13045_2022_Article_1375.pdf
View BVdb publication page



Emerging insights to lung cancer drug resistance.

Cancer Drug Resistance (Alhambra, Calif.)
Su, Chunxia C
Publication Date: 2022

Variant appearance in text: KRAS: R68S
PubMed Link: 36176761
Variant Present in the following documents:
  • cdr-5-3-534.pdf
View BVdb publication page



Conquering oncogenic KRAS and its bypass mechanisms.

Theranostics
Hou, Pingping P; Wang, Y Alan YA
Publication Date: 2022

Variant appearance in text: KRAS: R68S
PubMed Link: 35966590
Variant Present in the following documents:
  • Main text
  • thnov12p5691.pdf
View BVdb publication page



Targeting KRAS mutant cancers: from druggable therapy to drug resistance.

Molecular Cancer
Zhu, Chunxiao C; Guan, Xiaoqing X; Zhang, Xinuo X; Luan, Xin X; Song, Zhengbo Z; Cheng, Xiangdong X; Zhang, Weidong W; Qin, Jiang-Jiang JJ
Publication Date: 2022-08-04

Variant appearance in text: KRAS: R68S
PubMed Link: 35922812
Variant Present in the following documents:
  • Main text
  • 12943_2022_Article_1629.pdf
View BVdb publication page



Targeting Mutant Kirsten Rat Sarcoma Viral Oncogene Homolog in Non-Small Cell Lung Cancer: Current Difficulties, Integrative Treatments and Future Perspectives.

Frontiers In Pharmacology
Li, Jia-Xin JX; Li, Run-Ze RZ; Ma, Lin-Rui LR; Wang, Peng P; Xu, Dong-Han DH; Huang, Jie J; Li, Li-Qi LQ; Tang, Ling L; Xie, Ying Y; Leung, Elaine Lai-Han EL; Yan, Pei-Yu PY
Publication Date: 2022

Variant appearance in text: KRAS: R68S
PubMed Link: 35517800
Variant Present in the following documents:
  • Main text
  • fphar-13-875330.pdf
View BVdb publication page



A saturation mutagenesis screen uncovers resistant and sensitizing secondary KRAS mutations to clinical KRASG12C inhibitors.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Feng, Siyu S; Callow, Marinella G MG; Fortin, Jean-Philippe JP; Khan, Zia Z; Bray, David D; Costa, Mike M; Shi, Zhen Z; Wang, Weiru W; Evangelista, Marie M
Publication Date: 2022-05-03

Variant appearance in text: KRAS: R68S
PubMed Link: 35471904
Variant Present in the following documents:
  • pnas.202120512.pdf
  • pnas.2120512119.sapp.pdf
View BVdb publication page



Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies.

International Journal Of Molecular Sciences
Shetu, Shaila A SA; Bandyopadhyay, Debasish D
Publication Date: 2022-03-28

Variant appearance in text: KRAS: R68S
PubMed Link: 35409064
Variant Present in the following documents:
  • Main text
  • ijms-23-03706.pdf
View BVdb publication page



Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C.

Cancer Discovery
Weiss, Andreas A; Lorthiois, Edwige E; Barys, Louise L; Beyer, Kim S KS; Bomio-Confaglia, Claudio C; Burks, Heather H; Chen, Xueying X; Cui, Xiaoming X; de Kanter, Ruben R; Dharmarajan, Lekshmi L; Fedele, Carmine C; Gerspacher, Marc M; Guthy, Daniel Alexander DA; Head, Victoria V; Jaeger, Ashley A; Núñez, Eloísa Jiménez EJ; Kearns, Jeffrey D JD; Leblanc, Catherine C; Maira, Sauveur-Michel SM; Murphy, Jason J; Oakman, Helen H; Ostermann, Nils N; Ottl, Johannes J; Rigollier, Pascal P; Roman, Danielle D; Schnell, Christian C; Sedrani, Richard R; Shimizu, Toshio T; Stringer, Rowan R; Vaupel, Andrea A; Voshol, Hans H; Wessels, Peter P; Widmer, Toni T; Wilcken, Rainer R; Xu, Kun K; Zecri, Frederic F; Farago, Anna F AF; Cotesta, Simona S; Brachmann, Saskia M SM
Publication Date: 2022-06-02

Variant appearance in text: KRAS: R68S
PubMed Link: 35404998
Variant Present in the following documents:
  • Main text
  • 1500.pdf
  • cd-22-0158_supp1.pdf
View BVdb publication page



Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies.

Frontiers In Oncology
Désage, Anne-Laure AL; Léonce, Camille C; Swalduz, Aurélie A; Ortiz-Cuaran, Sandra S
Publication Date: 2022

Variant appearance in text: KRAS: R68S
PubMed Link: 35251972
Variant Present in the following documents:
  • Main text
  • fonc-12-796832.pdf
View BVdb publication page



Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition.

Scientific Reports
Vaclova, Tereza T; Chakraborty, Atanu A; Sherwood, James J; Ross, Sarah S; Carroll, Danielle D; Barrett, J Carl JC; Downward, Julian J; de Bruin, Elza C EC
Publication Date: 2022-02-17

Variant appearance in text: KRAS: R68S
PubMed Link: 35177674
Variant Present in the following documents:
  • Main text
  • 41598_2022_Article_6369.pdf
View BVdb publication page



Targeting KRAS in Non-Small Cell Lung Cancer.

Frontiers In Oncology
Corral de la Fuente, Elena E; Olmedo Garcia, Maria Eugenia ME; Gomez Rueda, Ana A; Lage, Yolanda Y; Garrido, Pilar P
Publication Date: 2021

Variant appearance in text: KRAS: R68S
PubMed Link: 35083149
Variant Present in the following documents:
  • Main text
View BVdb publication page



A Breakthrough Brought about by Targeting KRASG12C: Nonconformity Is Punished.

Cancers
Ning, Wenjuan W; Yang, Zhang Z; Kocher, Gregor J GJ; Dorn, Patrick P; Peng, Ren-Wang RW
Publication Date: 2022-01-13

Variant appearance in text: KRAS: R68S
PubMed Link: 35053550
Variant Present in the following documents:
  • Main text
View BVdb publication page



A Breakthrough Brought about by Targeting KRASG12C: Nonconformity Is Punished.

Cancers
Ning, Wenjuan W; Yang, Zhang Z; Kocher, Gregor J GJ; Dorn, Patrick P; Peng, Ren-Wang RW
Publication Date: 2022-01-13

Variant appearance in text: KRAS: R68S
PubMed Link: 35053550
Variant Present in the following documents:
  • Main text
View BVdb publication page



The path to the clinic: a comprehensive review on direct KRASG12C inhibitors.

Journal Of Experimental & Clinical Cancer Research : Cr
Kwan, Albert K AK; Piazza, Gary A GA; Keeton, Adam B AB; Leite, Caio A CA
Publication Date: 2022-01-19

Variant appearance in text: KRAS: R68S
PubMed Link: 35045886
Variant Present in the following documents:
  • Main text
  • 13046_2021_Article_2225.pdf
View BVdb publication page



The path to the clinic: a comprehensive review on direct KRASG12C inhibitors.

Journal Of Experimental & Clinical Cancer Research : Cr
Kwan, Albert K AK; Piazza, Gary A GA; Keeton, Adam B AB; Leite, Caio A CA
Publication Date: 2022-01-19

Variant appearance in text: KRAS: R68S
PubMed Link: 35045886
Variant Present in the following documents:
  • Main text
  • 13046_2021_Article_2225.pdf
View BVdb publication page



Resistance to KRASG12C Inhibitors in Non-Small Cell Lung Cancer.

Frontiers In Oncology
Blaquier, Juan Bautista JB; Cardona, Andrés Felipe AF; Recondo, Gonzalo G
Publication Date: 2021

Variant appearance in text: KRAS: R68S
PubMed Link: 35004309
Variant Present in the following documents:
  • Main text
View BVdb publication page



Untangling the KRAS mutated lung cancer subsets and its therapeutic implications.

Molecular Biomedicine
Ritu, Kulshrestha K; Kumar, Pawan P; Singh, Amit A; Nupur, K K; Spalgias, Sonam S; Mrigpuri, Parul P; Rajkumar,
Publication Date: 2021-12-17

Variant appearance in text: KRAS: R68S
PubMed Link: 34918209
Variant Present in the following documents:
  • Main text
  • 43556_2021_Article_61.pdf
View BVdb publication page



Untangling the KRAS mutated lung cancer subsets and its therapeutic implications.

Molecular Biomedicine (Online)
Ritu, Kulshrestha K; Kumar, Pawan P; Singh, Amit A; Nupur, K K; Spalgias, Sonam S; Mrigpuri, Parul P; Rajkumar,
Publication Date: 2021-12-17

Variant appearance in text: KRAS: R68S
PubMed Link: 34918209
Variant Present in the following documents:
  • Main text
  • 43556_2021_Article_61.pdf
View BVdb publication page



Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer.

Cancers
Sunaga, Noriaki N; Miura, Yosuke Y; Kasahara, Norimitsu N; Sakurai, Reiko R
Publication Date: 2021-11-26

Variant appearance in text: KRAS: R68S
PubMed Link: 34885068
Variant Present in the following documents:
  • Main text
View BVdb publication page



Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer.

Cancers
Sunaga, Noriaki N; Miura, Yosuke Y; Kasahara, Norimitsu N; Sakurai, Reiko R
Publication Date: 2021-11-26

Variant appearance in text: KRAS: R68S
PubMed Link: 34885068
Variant Present in the following documents:
  • Main text
View BVdb publication page



Selective KRAS G12C inhibitors in non-small cell lung cancer: chemistry, concurrent pathway alterations, and clinical outcomes.

Npj Precision Oncology
Palma, Gabriela G; Khurshid, Faisal F; Lu, Kevin K; Woodward, Brian B; Husain, Hatim H
Publication Date: 2021-11-29

Variant appearance in text: KRAS: R68S
PubMed Link: 34845311
Variant Present in the following documents:
  • Main text
  • 41698_2021_Article_237.pdf
View BVdb publication page



KRAS mutation: from undruggable to druggable in cancer.

Signal Transduction And Targeted Therapy
Huang, Lamei L; Guo, Zhixing Z; Wang, Fang F; Fu, Liwu L
Publication Date: 2021-11-15

Variant appearance in text: KRAS: R68S
PubMed Link: 34776511
Variant Present in the following documents:
  • Main text
View BVdb publication page